These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11966697)

  • 1. Cutaneous adverse reactions to clindamycin: results of skin tests and oral exposure.
    Lammintausta K; Tokola R; Kalimo K
    Br J Dermatol; 2002 Apr; 146(4):643-8. PubMed ID: 11966697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of patch tests in clindamycin-related drug eruptions.
    Pereira N; Canelas MM; Santiago F; Brites MM; Gonçalo M
    Contact Dermatitis; 2011 Oct; 65(4):202-7. PubMed ID: 21689110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalized reactions during skin testing with clindamycin in drug hypersensitivity: a report of 3 cases and review of the literature.
    Papakonstantinou E; Müller S; Röhrbein JH; Wieczorek D; Kapp A; Jakob T; Wedi B
    Contact Dermatitis; 2018 Apr; 78(4):274-280. PubMed ID: 29356000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing.
    El Khoury M; Assier H; Gener G; Paul M; Haddad C; Chosidow O; Wolkenstein P; Ingen-Housz-Oro S
    Br J Dermatol; 2018 Oct; 179(4):978-979. PubMed ID: 29747236
    [No Abstract]   [Full Text] [Related]  

  • 6. Clindamycin skin testing has limited diagnostic potential.
    Notman MJ; Phillips EJ; Knowles SR; Weber EA; Shear NH
    Contact Dermatitis; 2005 Dec; 53(6):335-8. PubMed ID: 16364122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergy diagnostic testing in clindamycin-induced skin reactions.
    Seitz CS; Bröcker EB; Trautmann A
    Int Arch Allergy Immunol; 2009; 149(3):246-50. PubMed ID: 19218817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patch testing for evaluating drug reactions due to systemic antibiotics.
    Cham PM; Warshaw EM
    Dermatitis; 2007 Jun; 18(2):63-77. PubMed ID: 17498411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of skin tests to prove drug hypersensitivity.
    Lammintausta K; Kortekangas-Savolainen O
    Br J Dermatol; 2005 May; 152(5):968-74. PubMed ID: 15888154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of patch testing for the diagnosis of delayed-type drug hypersensitivity reactions to clindamycin.
    Gilissen L; Huygens S; Goossens A; Breynaert C; Schrijvers R
    Contact Dermatitis; 2020 Sep; 83(3):237-239. PubMed ID: 32333605
    [No Abstract]   [Full Text] [Related]  

  • 11. Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole.
    Dilley M; Geng B
    Clin Rev Allergy Immunol; 2022 Jun; 62(3):463-475. PubMed ID: 34910281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed reaction to oral treatment with clindamycin.
    Vicente J; Fontela JL
    Contact Dermatitis; 1999 Oct; 41(4):221. PubMed ID: 10515103
    [No Abstract]   [Full Text] [Related]  

  • 13. Clindamycin-associated acute generalized exanthematous pustulosis.
    Valois M; Phillips EJ; Shear NH; Knowles SR
    Contact Dermatitis; 2003 Mar; 48(3):169. PubMed ID: 12755740
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of skin testing in the investigation of cutaneous adverse drug reactions.
    Barbaud A; Reichert-Penetrat S; Tréchot P; Jacquin-Petit MA; Ehlinger A; Noirez V; Faure GC; Schmutz JL; Béné MC
    Br J Dermatol; 1998 Jul; 139(1):49-58. PubMed ID: 9764148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term reproducibility of positive patch test reactions in patients with non-immediate cutaneous adverse drug reactions to antibiotics.
    Pinho A; Marta A; Coutinho I; Gonçalo M
    Contact Dermatitis; 2017 Apr; 76(4):204-209. PubMed ID: 27910104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergy to beta-lactam antibiotics in children.
    Ponvert C; Le Clainche L; de Blic J; Le Bourgeois M; Scheinmann P; Paupe J
    Pediatrics; 1999 Oct; 104(4):e45. PubMed ID: 10506270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis.
    Caumes E; Bocquet H; Guermonprez G; Rogeaux O; Bricaire F; Katlama C; Gentilini M
    Clin Infect Dis; 1995 Sep; 21(3):656-8. PubMed ID: 8527561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct oral provocation tests in non-immediate mild cutaneous reactions related to beta-lactam antibiotics.
    Vezir E; Dibek Misirlioglu E; Civelek E; Capanoglu M; Guvenir H; Ginis T; Toyran M; Kocabas CN
    Pediatr Allergy Immunol; 2016 Feb; 27(1):50-4. PubMed ID: 26619970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period.
    Lammintausta K; Kortekangas-Savolainen O
    Acta Derm Venereol; 2005; 85(6):491-6. PubMed ID: 16396795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.